Curative Ventures V LLC Amends Instil Bio Stake Filing
Ticker: TIL · Form: SC 13D/A · Filed: Oct 22, 2024 · CIK: 1789769
| Field | Detail |
|---|---|
| Company | Instil Bio, INC. (TIL) |
| Form Type | SC 13D/A |
| Filed Date | Oct 22, 2024 |
| Risk Level | medium |
| Pages | 7 |
| Reading Time | 8 min |
| Key Dollar Amounts | $0.000001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, schedule-13d, ownership-change
Related Tickers: ISRB
TL;DR
Curative Ventures V LLC updated its Instil Bio filing on 10/22/24. Ownership details changed.
AI Summary
Curative Ventures V LLC, through an amendment filed on October 22, 2024, has updated its Schedule 13D regarding its holdings in Instil Bio, Inc. The filing indicates a change in the reporting person's beneficial ownership, though specific new dollar amounts or exact share counts are not detailed in this excerpt. The event requiring this filing occurred on August 6, 2022.
Why It Matters
This amendment signals a potential shift in significant ownership or control of Instil Bio, Inc., which could impact the company's stock price and strategic direction.
Risk Assessment
Risk Level: medium — Amendments to Schedule 13D filings often indicate changes in significant shareholder positions, which can lead to increased volatility.
Key Players & Entities
- Curative Ventures V LLC (company) — Reporting Person
- Instil Bio, Inc. (company) — Subject Company
- BRONSON CROUCH (person) — Group Member
- CV-IMMETACYTE MANAGER LP (company) — Group Member
- CV-IMMETACYTE ULTIMATE MANAGER LLC (company) — Group Member
- SB2A LP (company) — Group Member
- SB2A MANAGEMENT LLC (company) — Group Member
FAQ
What specific changes were made in the beneficial ownership of Instil Bio, Inc. by Curative Ventures V LLC in this amendment?
This excerpt does not specify the exact changes in beneficial ownership, only that an amendment was filed on October 22, 2024, to Schedule 13D.
When was the original event that triggered the initial filing requirement for this Schedule 13D?
The date of the event which requires filing was August 6, 2022.
What is the business address for Curative Ventures V LLC?
The business address for Curative Ventures V LLC is 3963 Maple Avenue, Suite 390, Dallas, Texas 75219.
What is the CUSIP number for Instil Bio, Inc. common stock?
The CUSIP number for Instil Bio, Inc. common stock is 4578C101.
Who are the listed group members associated with this filing?
The listed group members are BRONSON CROUCH, CV-IMMETACYTE MANAGER LP, CV-IMMETACYTE ULTIMATE MANAGER LLC, SB2A LP, and SB2A MANAGEMENT LLC.
Filing Stats: 1,955 words · 8 min read · ~7 pages · Grade level 15.8 · Accepted 2024-10-22 18:21:56
Key Financial Figures
- $0.000001 — me of Issuer) Common Stock, par value $0.000001 (Title of Class of Securities) 4578
Filing Documents
- d890198dsc13da.htm (SC 13D/A) — 135KB
- d890198dex99a.htm (EX-99.A) — 9KB
- 0001193125-24-241198.txt ( ) — 146KB
From the Filing
SC 13D/A 1 d890198dsc13da.htm SC 13D/A SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Instil Bio, Inc. (Name of Issuer) Common Stock, par value $0.000001 (Title of Class of Securities) 4578C101 (CUSIP NUMBER) Curative Ventures V LLC 3963 Maple Avenue Suite 390 Dallas, Texas 75219 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 6, 2022 (Date of event which requires filing of this statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g) check the following box. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the Act), or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP No. 45783C101 13D 1 NAMES OF REPORTING PERSONS Curative Ventures V LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS* WC 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 8 SHARED VOTING POWER 1,899,003 9 SOLE DISPOSITIVE POWER 0 10 SHARED DISPOSITIVE POWER 1,899,003 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,899,003 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 29.2% 14 TYPE OF REPORTING PERSON* OO * SEE INSTRUCTIONS BEFORE FILLING OUT CUSIP No. 45783C101 13D 1 NAMES OF REPORTING PERSONS CV-Immetacyte Manager LP 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS* AF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 8 SHARED VOTING POWER 1,899,003 9 SOLE DISPOSITIVE POWER 0 10 SHARED DISPOSITIVE POWER 1,899,003 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,899,003 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 29.2% 14 TYPE OF REPORTING PERSON* OO * SEE INSTRUCTIONS BEFORE FILLING OUT CUSIP No. 45783C101 13D 1 NAMES OF REPORTING PERSONS CV-Immetacyte Ultimate Manager LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS* AF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 8 SHARED VOTING POWER 1,899,003 9 SOLE DISPOSITIVE POWER 0 10 SHARED DISPOSITIVE POWER 1,899,003 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,899,003 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 29.2% 14 TYPE OF REPORTING PERSON* OO * SEE INSTRUCTIONS BEFORE FILLING OUT CUSIP No. 45783C101 13D 1 NAMES OF REPORTING PERSONS SB2A LP 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS* AF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 8 SHARED VOTING POWER 2,019,002 9 SOLE DISPOSITIVE POWER 10 SHARED DISPOSITIVE POWER 2,019,002 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,019,002 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 31.0% 14 TYPE OF REPORTING PERSON* PN CUSIP No. 45783C101 13D 1 NAMES OF REPORTING PERSONS SB2A Management LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER